Smith, Ruben http://orcid.org/0000-0001-7147-0112
Schöll, Michael http://orcid.org/0000-0001-7800-1781
Londos, Elisabet
Ohlsson, Tomas
Hansson, Oskar
Article History
Received: 23 November 2017
Accepted: 5 March 2018
First Online: 16 March 2018
Competing Interests
: R.S., M.S., E.L. and T.O. report no disclosures. O.H. has acquired research support (for the institution) from Roche, GE Healthcare, Biogen, AVID Radiopharmaceuticals, Fujirebio, and Euroimmun. In the past 2 years, he has received consultancy/speaker fees (paid to the institution) from Lilly, Roche, and Fujirebio.